- Home
- LUMN vs RGC Comparison
LUMN vs RGC Comparison
Compare LUMN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LUMN | RGC |
|---|---|---|
| Founded | 1968 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.4B |
| IPO Year | 1972 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LUMN | RGC |
|---|---|---|
| Price | $8.07 | $16.95 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.73 | N/A |
| AVG Volume (30 Days) | ★ 13.7M | 210.3K |
| Earning Date | 02-03-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,690,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.01 | $0.09 |
| 52 Week High | $11.95 | $83.60 |
Technical Indicators
Market Signals| Indicator | LUMN | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 61.44 |
| Support Level | $8.13 | $16.10 |
| Resistance Level | $8.96 | $18.10 |
| Average True Range (ATR) | 0.53 | 1.59 |
| MACD | -0.03 | 0.56 |
| Stochastic Oscillator | 19.80 | 83.25 |
Price Performance
Historical ComparisonAbout LUMN Lumen Technologies Inc.
Lumen Technologies is one of the largest telecommunications carriers serving global enterprises. The merger with Level 3 in 2017 and the 2022 divestiture of much of its local phone business in rural areas and small markets shifted the company's operations away from the legacy consumer business and toward enterprises services, which account for about 75% of revenue. Lumen offers businesses a full suite of communications services, providing colocation and data center services, data transportation, phone service, and internet access. Lumen has announced the sale of its remaining consumer fiber network to AT&T, which will further shift its focus to enterprise customers.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.